Stockscreener 앱 받기
6.77
0.29%
-0.02
Certara Inc 주식(CERT)의 최신 뉴스
What Certara (CERT)'s NVIDIA BioNeMo Partnership Means For Shareholders - Sahm
Certara faces securities fraud probe after Q1 r... - Pluang
BlackRock (CERT) discloses 18.0M shares; 11.6% ownership reported - Stock Titan
AI Chips TodayCertara-NVIDIA Partnership Revolutionizes AI in Drug Development - Yahoo Finance
Certara partners with Nvidia to integrate AI agents into drug development platform - Investing.com UK
Nvidia Powers AI Agent Strategies for Certara, Silo PharmaNVIDIA (NASDAQ:NVDA) - Benzinga
Certara teams up with Nvidia to strengthen AI platform with BioNeMo toolkit (CERT) - Yahoo Finance
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit - The Manila Times
Certara Accelerates Drug Discovery and Development With NVIDIA BioNeMo Agent Toolkit - 富途牛牛
Price to earnings forward of Certara, Inc. – HAM:700 - TradingView
Why Did CERT Stock Fall Today? - Stocktwits
Enterprise value to revenue forward of Certara, Inc. – NASDAQ:CERT - TradingView
Certara Inc (NASDAQ: CERT) Share Price, CERT Stock News, CERT Share Price & Updates - Kalkine
Is Certara (CERT) Quietly Recasting Its Small-Cap Identity Around Biosimulation Advisory Leadership? - Yahoo Finance
Franklin Covey Cuts Revenue Forecast, Joins Ouster And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session - Sahm
Does Certara (CERT) Joining the Russell 2000 Recast Its Biosimulation Investment Narrative? - simplywall.st
Trading the Move, Not the Narrative: (CERT) Edition - Stock Traders Daily
William Blair Maintains Certara(CERT.US) With Hold Rating - Moomoo
Should You Investigate Certara, Inc. (NASDAQ:CERT) At US$6.36? - Moomoo
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Pomerantz investigates Certara for potential se... - Pluang
Certara, Inc.(NasdaqGS: CERT) added to Russell 2000 Index - marketscreener.com
Certara, Inc.(NasdaqGS: CERT) dropped from Russell Midcap Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Certara, Inc. – NASDAQ:CERT - TradingView
Certara, Inc.(NasdaqGS: CERT) dropped from Russell 1000 Index - marketscreener.com
Enterprise value to EBIT forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to book forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to book forward of Certara, Inc. – BMV:CERT - TradingView
Price to earnings forward of Certara, Inc. – BMV:CERT - TradingView
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
Certara, Inc. Actuals & Estimates (NASDAQ:CERT) - TradingView
CERT Forecast — Price Target — Prediction for 2027 - TradingView
Certara Q1 2026 Earnings: EPS Misses Estimates Amid Challenging QuarterAnalyst Consensus Shift - dars.gov.et
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-Risk Investment and Accelerate Development - marketscreener.com
CERT Stock Slides As Certara Faces Probes And CFO Exit - timothysykes.com
Certara StockLaw Firm Launches Investigation After Share Price Slide - AD HOC NEWS
Certara names Faiz Mohammed interim CFO as John Gallagher steps down - MSN
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets - Yahoo Finance
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. - GlobeNewswire
(CERT) Volatility Zones as Tactical Triggers - Stock Traders Daily
Certara, Inc. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Certara Appoints Interim CFO Amid Leadership Transition - The Globe and Mail
Investigation launched into Certara over stock losses after weak Q1 results and CFO resignation - Pluang
SMID Core Equity Portfolio's Certara Inc(CERT) Holding History - GuruFocus
Certara (CERT) CFO John Gallagher Announces Resignation, Interim Successor Appointed - GuruFocus
Certara Announces CFO Transition, Names Interim CFO, and Reaffirms 2026 Financial Guidance - Minichart
Certara (CERT) CFO John Gallagher to Resign in 2026, Interim Suc - GuruFocus
Certara CFO John Gallagher to resign, reaffirms 2026 guidance By Investing.com - Investing.com South Africa
Certara CFO John Gallagher to resign, reaffirms 2026 guidance - Investing.com
Certara Announces CFO Transition - The Manila Times
CFO transition at Certara (NASDAQ: CERT) as company reaffirms 2026 guidance - Stock Titan
Certara, Inc. Announces Executive Changes - marketscreener.com
3.61%
자본화:
|
볼륨(24시간):